Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
Manufacturing
Indian API maker Cdymax hit with warning letter tied to testing
The letter comes in response to an earlier Form 483 the FDA issued after inspecting Cdymax's facility from April 21-25.
Joseph Keenan
Nov 20, 2025 9:27am
Emcure partners with Novo to increase access to Wegovy in India
Nov 10, 2025 11:47am
FDA scolds Hetero over missteps at India warehouse
Oct 28, 2025 10:00am
ACG pumps $200M into its first US empty-capsule facility
Oct 21, 2025 8:50am
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
Oct 10, 2025 10:55am
Lupin to lay out $250M for new Fla. manufacturing facility
Oct 9, 2025 9:02am
